SCHEMBL4834335

SCHEMBL4834335

COC(=O)c1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cccc(C(F)(F)F)c3)cc2)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RORC P51449 8/20 0.39
MCHR1 Q99705 1/20 0.38
MAPT P10636 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
CACNA1B Q00975 1/20 0.35
MMP8 P22894 2/20 0.35
POLB P06746 1/20 0.35
MMP3 P08254 1/20 0.35
ERAP2 Q6P179 1/20 0.35
ERAP1 Q9NZ08 1/20 0.35
TRPA1 O75762 1/20 0.35
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841474 0.93 RORC (0.39) RORCMCHR1MAPTPSEN1PSEN2
SCHEMBL4845234 0.93 RORC (0.39) RORCMCHR1MAPTPSEN1PSEN2
SCHEMBL4839389 0.93 RORC (0.39) RORCMCHR1MMP8MMP3TRPA1
SCHEMBL4842584 0.93 MRGPRX4 (0.40) RORCMCHR1MAPTPSEN1PSEN2
SCHEMBL4840174 0.92 RORC (0.41) RORCMAPTPOLBTRPA1
SCHEMBL4837216 0.90 RORC (0.43) RORCMAPTCACNA1BPOLBMAPK1
SCHEMBL4840811 0.88 RORC (0.39) RORCMAPTMMP8POLBMMP3
SCHEMBL4845108 0.87 RORC (0.39) RORCMCHR1MMP8MMP3
SCHEMBL4838028 0.87 TRPA1 (0.42) RORCMAPTPSEN1PSEN2APH1B
SCHEMBL4842782 0.87 TRPA1 (0.39) RORCMAPTPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 RORC 1777/4885MCHR1 312/4885MAPT 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.